Clinical trial / 2015
Almond supplementation increased serum HDL cholesterol in coronary artery disease patients with low baseline HDL.
In a randomized controlled trial, 150 coronary artery disease patients with low baseline HDL cholesterol were assigned to receive 10 g/d of Pakistani almonds, 10 g/d of American almonds, or no intervention for 12 weeks. At weeks 6 and 12, HDL cholesterol was 12-14% and 14-16% higher than baseline, respectively, in both almond groups. Both almond groups also had significant reductions compared to baseline in total cholesterol, triglycerides, LDL cholesterol, VLDL cholesterol, total-to-HDL and LDL-to-HDL ratios, and the atherogenic index (P < 0.05), with no differences between almond varieties. Dietary patterns, body weight, and blood pressure did not change in any group.
- Study type
- Randomized controlled trial
- Who was studied
- 150 CAD patients recruited from Aga Khan University Hospital
- What was measured
- Serum lipid profile, body weight, blood pressure, and dietary patterns
THE PAPER
Dietary Almonds Increase Serum HDL Cholesterol in Coronary Artery Disease Patients in a Randomized Controlled Trial.
Jamshed H, Sultan FA, Iqbal R, Gilani AH. J Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.